A Surgical Window of Opportunity Clinical Trial of Troriluzole in Recurrent IDH Wild-Type Glioblastoma

NCT06552260 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma
Recurrent Glioblastoma
Brain Tumor

Interventions

DRUG: Troriluzole

Sponsor

Ugonma Chukwueke

Collaborators

[object Object]
[object Object]